Malick Minkael Sylla
YOU?
Author Swipe
View article: Haematological and Biochemical Reference Values for Healthy Population of Maferinyah Rural Community in Guinea
Haematological and Biochemical Reference Values for Healthy Population of Maferinyah Rural Community in Guinea Open
Guinea’s reference ranges for biological parameters rely on those of Caucasian values. Variability in reference ranges according to the context is well‐documented. We conducted this study for the purpose of future malaria clinical trials t…
View article: Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial Open
View article: IMPACT OF TREATMENT OF UNCOMPLICATED MALARIA BY AMODIAQUINE−ARTESUNATE (AS-AQ) ON PFCRT 76T AND PFMDR1 86Y MUTATIONS SELECTION IN<i>PLASMODIUM FALCIPARUM</i>ISOLATES, REPUBLIC OF GUINEA
IMPACT OF TREATMENT OF UNCOMPLICATED MALARIA BY AMODIAQUINE−ARTESUNATE (AS-AQ) ON PFCRT 76T AND PFMDR1 86Y MUTATIONS SELECTION IN<i>PLASMODIUM FALCIPARUM</i>ISOLATES, REPUBLIC OF GUINEA Open
Background The use of Amodiaquine monotherapy is associated with the selection of resistance markers ( Pfcrt and Pfmd r1). The decrease in sensitivity and the emergence of Plasmodium falciparum -resistant strains have been reported. It is …
View article: Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial Open